Observational study of skin disease patients
Part of Genetic & congenital, Immune system & allergy, Infections, Skin clinical trials.
This study looks at the health records of people with skin diseases to learn more about their care and outcomes. It may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child or adult with a skin disease diagnosis.
- Your doctor must agree to share your health information for research.
- You must be willing to participate in the study activities.
- You must not have withdrawn from the study or failed to complete required activities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
This study looks at the health records of people with certain inflammatory skin diseases (such as psoriasis or eczema) in Italy to understand who gets them and what treatments they receive. By joining, you help doctors learn more about how these conditions are managed in real life.
This study looks at how certain skin conditions affect daily life in teens and adults. Researchers want to understand the challenges people face with vitiligo, alopecia areata, or hidradenitis suppurativa by having participants fill out simple questionnaires.
This study follows people with chronic skin conditions over time, using questionnaires and photos taken at home. It tests whether digital monitoring can improve care and help doctors track your condition between visits.
This study collects skin samples (like small biopsies or swabs) from people with certain skin conditions and from healthy volunteers. The samples help researchers learn more about these conditions and may lead to better treatments.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.